Earnings Call · Q2 FY2026·2026-08-13

Q2 26EPS -20.69%·Rev n/aQ1 26EPS -23.43%·Rev n/aQ4 25EPS -12.73%·Rev n/aQ3 25EPS 0.00%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

AJ Bergmann — Chief Financial Officer

Linda Marbán — Chief Executive Officer

+58.0%1d on move date3d+68.2%5d+62.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access